Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,828 | -17,609 | -8,099 | -43,883 | -24,271 |
| Depreciation Amortization | 5,045 | 3,410 | 1,627 | 3,278 | 2,342 |
| Income taxes - deferred | -5,175 | -2,862 | -1,349 | -3,281 | 0 |
| Accounts receivable | -20 | -170 | 178 | 379 | 867 |
| Other Working Capital | -1,949 | -2,795 | -1,717 | 2,731 | 1,260 |
| Other Operating Activity | -1,817 | -1,109 | -997 | 11,267 | -1,080 |
| Operating Cash Flow | $-29,744 | $-21,135 | $-10,357 | $-29,509 | $-20,882 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -493 | -401 | -228 | -2,246 | -1,945 |
| Other Investing Activity | -306 | -306 | -300 | -1,419 | -62 |
| Investing Cash Flow | $-799 | $-707 | $-528 | $-3,665 | $-2,007 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 467 | 0 | N/A | N/A | 0 |
| Debt Repayment | -13 | 0 | 0 | N/A | 0 |
| Common Stock Issued | 28,994 | 28,994 | 8,841 | 35,082 | 25,885 |
| Other Financing Activity | 3,202 | 3,198 | 3,288 | -818 | -748 |
| Financing Cash Flow | $32,650 | $32,192 | $12,129 | $34,264 | $25,137 |
| Exchange Rate Effect | -186 | -123 | -101 | 56 | 119 |
| Beginning Cash Position | 5,495 | 5,495 | 5,496 | 4,350 | 4,350 |
| End Cash Position | 7,416 | 15,722 | 6,638 | 5,496 | 6,717 |
| Net Cash Flow | $1,921 | $10,227 | $1,142 | $1,146 | $2,367 |
| Free Cash Flow | |||||
| Operating Cash Flow | -29,744 | -21,135 | -10,357 | -29,509 | -20,882 |
| Capital Expenditure | -497 | -405 | -232 | -2,277 | -1,976 |
| Free Cash Flow | -30,241 | -21,540 | -10,589 | -31,786 | -22,858 |